Printer Friendly

Chloramphenicol contamination. (Clinical Capsules).

Sampling of imported shrimp and crayfish will be increased due to detection of chloramphenicol in these products, the U.S. Food and Drug Administration announced.

Due to chloramphenicol's potency and the lack of a known safe level of human exposure, the broad-spectrum antibiotic is reserved for the treatment of serious infections. Federal regulations prohibit its use in animal feed and in animals used for food.

The detection of even low levels of chloramphenicol in food products is of concern, and entry to the United States of any product found to be contaminated with the drug will be refused, according to the FDA.
COPYRIGHT 2002 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Worcester, Sharon
Publication:Internal Medicine News
Article Type:Brief Article
Geographic Code:1USA
Date:Jul 15, 2002
Previous Article:HGE treatment outcomes. (Clinical Capsules).
Next Article:Narcotic tampering. (Clinical Capsules).

Related Articles
Lack of Evidence for Chloramphenicol Resistance in Neisseria meningitidis, Africa.
Wal-Mart resumes sales of crawfish tails. (Restaurant and Food).
Asian shrimp industry coming to grips with technical roadblocks to imports: Thailand and nearby countries make moves to eliminate chloramphenicol and...
Your problems: Jelly's off the menu.
Adulterated honey. (Clinical Capsules).
Meningococcal meningitis Rx.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters